Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Venrock, founded in 1969, serves as the venture capital arm of the Rockefeller family, with its headquarters located in Palo Alto, California. The firm has a rich history of over 55 years in the venture capital landscape, focusing primarily on technology and healthcare sectors. Venrock has established itself as a prominent player in the industry, known for its strategic partnerships with entrepreneurs who are addressing significant challenges in these fields. The firm has raised multiple funds over the decades, with a notable portfolio that includes high-profile companies such as Apple, Intel, Gilead Sciences, and Check Point. Venrock's long-term perspective, combined with its deep expertise in technology and healthcare, allows it to provide valuable insights and resources to its portfolio companies. The firm operates primarily in North America, leveraging its extensive network to support innovative startups that have the potential to disrupt existing markets.
Venrock's investment focus is centered on partnering with entrepreneurs who are tackling big, hard problems that many consider impossible. The firm primarily invests in the technology and healthcare sectors, recognizing the transformative potential of innovations in these areas. Venrock's check sizes range from $2 million to $20 million, allowing them to participate in various stages of funding, including seed, Series A, and Series B rounds. The firm is particularly interested in companies that are developing groundbreaking solutions in biotech, cybersecurity, healthcare, and SaaS. By focusing on these sectors, Venrock aims to identify and support innovative companies capable of making a significant impact in their respective markets. The firm's commitment to addressing substantial challenges positions it as a valuable partner for startups looking to scale their operations and achieve long-term success.
Venrock boasts a remarkable portfolio of notable investments, including industry giants such as Apple, Intel, Gilead Sciences, Check Point, and Athenahealth. The firm has also invested in innovative companies like Nest, Illumina, DoubleClick, and Imperva, showcasing its diverse interests across various sectors. Venrock's history of successful exits and IPOs underscores its ability to identify and nurture high-potential startups. The firm's strategic approach to investing has resulted in a robust portfolio that not only reflects its expertise in technology and healthcare but also highlights its commitment to supporting companies that are poised for growth and disruption. With a track record of backing transformative businesses, Venrock continues to play a pivotal role in shaping the future of these industries.
David Pakman - Partner, focuses on technology investments and has a strong background in consumer internet and software. Bob Kocher - Partner, specializes in healthcare investments and has extensive experience in the biotech sector. Nick Beim - Partner, focuses on early-stage investments in technology and has a background in entrepreneurship.
To pitch Venrock, entrepreneurs should prepare a detailed presentation that outlines their business model and growth strategy. While specific submission guidelines are not provided, a well-structured pitch is essential for consideration.
In December 2025, Venrock made its latest investment, continuing its active presence in the venture capital landscape. The firm has consistently sought out innovative companies in technology and healthcare, reinforcing its commitment to supporting disruptive solutions.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.